Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Longitudinal Trends in Childhood Insulin Levels and Body Mass Index and Associations With Risks of Psychosis and Depression in Young Adults

BI. Perry, J. Stochl, R. Upthegrove, S. Zammit, N. Wareham, C. Langenberg, E. Winpenny, D. Dunger, PB. Jones, GM. Khandaker

. 2021 ; 78 (4) : 416-425. [pub] 20210401

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
MC_UU_12015/1 Medical Research Council - United Kingdom
MR/L010305/1 Medical Research Council - United Kingdom
201486/Z/16/Z Wellcome Trust - United Kingdom
MC_PC_15018 Medical Research Council - United Kingdom
G9815508 Medical Research Council - United Kingdom
102215/2/13/2 Wellcome Trust - United Kingdom
MR/T010576/1 Medical Research Council - United Kingdom
MC_PC_17213 Medical Research Council - United Kingdom
217065/Z/19/Z Wellcome Trust - United Kingdom
MR/S037675/1 Medical Research Council - United Kingdom
MC_UU_00006/1 Medical Research Council - United Kingdom
08426812/Z/07/Z Wellcome Trust - United Kingdom
MC_PC_19009 Medical Research Council - United Kingdom
MR/M006727/1 Medical Research Council - United Kingdom
DRF-2018-11-ST2-018 Department of Health - United Kingdom

Importance: Cardiometabolic disorders often occur concomitantly with psychosis and depression, contribute to high mortality rates, and are detectable from the onset of the psychiatric disorders. However, it is unclear whether longitudinal trends in cardiometabolic traits from childhood are associated with risks for adult psychosis and depression. Objective: To examine whether specific developmental trajectories of fasting insulin (FI) levels and body mass index (BMI) from early childhood were longitudinally associated with psychosis and depression in young adults. Design, Setting, and Participants: A cohort study from the Avon Longitudinal Study of Parents and Children, a prospective study including a population-representative British cohort of 14 975 individuals, was conducted using data from participants aged 1 to 24 years. Body mass index and FI level data were used for growth mixture modeling to delineate developmental trajectories, and associations with psychosis and depression were assessed. The study was conducted between July 15, 2019, and March 24, 2020. Exposures: Fasting insulin levels were measured at 9, 15, 18, and 24 years, and BMI was measured at 1, 2, 3, 4, 7, 9, 10, 11, 12, 15, 18, and 24 years. Data on sex, race/ethnicity, paternal social class, childhood emotional and behavioral problems, and cumulative scores of sleep problems, average calorie intake, physical activity, smoking, and alcohol and substance use in childhood and adolescence were examined as potential confounders. Main Outcomes and Measures: Psychosis risk (definite psychotic experiences, psychotic disorder, at-risk mental state status, and negative symptom score) depression risk (measured using the computerized Clinical Interview Schedule-Revised) were assessed at 24 years. Results: From data available on 5790 participants (3132 [54.1%] female) for FI levels and data available on 10 463 participants (5336 [51.0%] female) for BMI, 3 distinct trajectories for FI levels and 5 distinct trajectories for BMI were noted, all of which were differentiated by mid-childhood. The persistently high FI level trajectory was associated with a psychosis at-risk mental state (adjusted odds ratio [aOR], 5.01; 95% CI, 1.76-13.19) and psychotic disorder (aOR, 3.22; 95% CI, 1.29-8.02) but not depression (aOR, 1.38; 95% CI, 0.75-2.54). A puberty-onset major increase in BMI was associated with depression (aOR, 4.46; 95% CI, 2.38-9.87) but not psychosis (aOR, 1.98; 95% CI, 0.56-7.79). Conclusions and Relevance: The cardiometabolic comorbidity of psychosis and depression may have distinct, disorder-specific early-life origins. Disrupted insulin sensitivity could be a shared risk factor for comorbid cardiometabolic disorders and psychosis. A puberty-onset major increase in BMI could be a risk factor or risk indicator for adult depression. These markers may represent targets for prevention and treatment of cardiometabolic disorders in individuals with psychosis and depression.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012495
003      
CZ-PrNML
005      
20220506131048.0
007      
ta
008      
220425s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1001/jamapsychiatry.2020.4180 $2 doi
035    __
$a (PubMed)33439216
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Perry, Benjamin I $u Department of Psychiatry, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom $u Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, United Kingdom
245    10
$a Longitudinal Trends in Childhood Insulin Levels and Body Mass Index and Associations With Risks of Psychosis and Depression in Young Adults / $c BI. Perry, J. Stochl, R. Upthegrove, S. Zammit, N. Wareham, C. Langenberg, E. Winpenny, D. Dunger, PB. Jones, GM. Khandaker
520    9_
$a Importance: Cardiometabolic disorders often occur concomitantly with psychosis and depression, contribute to high mortality rates, and are detectable from the onset of the psychiatric disorders. However, it is unclear whether longitudinal trends in cardiometabolic traits from childhood are associated with risks for adult psychosis and depression. Objective: To examine whether specific developmental trajectories of fasting insulin (FI) levels and body mass index (BMI) from early childhood were longitudinally associated with psychosis and depression in young adults. Design, Setting, and Participants: A cohort study from the Avon Longitudinal Study of Parents and Children, a prospective study including a population-representative British cohort of 14 975 individuals, was conducted using data from participants aged 1 to 24 years. Body mass index and FI level data were used for growth mixture modeling to delineate developmental trajectories, and associations with psychosis and depression were assessed. The study was conducted between July 15, 2019, and March 24, 2020. Exposures: Fasting insulin levels were measured at 9, 15, 18, and 24 years, and BMI was measured at 1, 2, 3, 4, 7, 9, 10, 11, 12, 15, 18, and 24 years. Data on sex, race/ethnicity, paternal social class, childhood emotional and behavioral problems, and cumulative scores of sleep problems, average calorie intake, physical activity, smoking, and alcohol and substance use in childhood and adolescence were examined as potential confounders. Main Outcomes and Measures: Psychosis risk (definite psychotic experiences, psychotic disorder, at-risk mental state status, and negative symptom score) depression risk (measured using the computerized Clinical Interview Schedule-Revised) were assessed at 24 years. Results: From data available on 5790 participants (3132 [54.1%] female) for FI levels and data available on 10 463 participants (5336 [51.0%] female) for BMI, 3 distinct trajectories for FI levels and 5 distinct trajectories for BMI were noted, all of which were differentiated by mid-childhood. The persistently high FI level trajectory was associated with a psychosis at-risk mental state (adjusted odds ratio [aOR], 5.01; 95% CI, 1.76-13.19) and psychotic disorder (aOR, 3.22; 95% CI, 1.29-8.02) but not depression (aOR, 1.38; 95% CI, 0.75-2.54). A puberty-onset major increase in BMI was associated with depression (aOR, 4.46; 95% CI, 2.38-9.87) but not psychosis (aOR, 1.98; 95% CI, 0.56-7.79). Conclusions and Relevance: The cardiometabolic comorbidity of psychosis and depression may have distinct, disorder-specific early-life origins. Disrupted insulin sensitivity could be a shared risk factor for comorbid cardiometabolic disorders and psychosis. A puberty-onset major increase in BMI could be a risk factor or risk indicator for adult depression. These markers may represent targets for prevention and treatment of cardiometabolic disorders in individuals with psychosis and depression.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    12
$a index tělesné hmotnosti $7 D015992
650    12
$a kardiometabolické riziko $7 D000083202
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a depresivní poruchy $x epidemiologie $7 D003866
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a inzulin $x krev $7 D007328
650    _2
$a longitudinální studie $7 D008137
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a psychotické poruchy $x epidemiologie $7 D011618
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Spojené království $x epidemiologie $7 D006113
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Stochl, Jan $u Department of Psychiatry, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom $u Department of Kinanthropology, Charles University, Prague, Czechia
700    1_
$a Upthegrove, Rachel $u Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom
700    1_
$a Zammit, Stan $u Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom $u MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, United Kingdom
700    1_
$a Wareham, Nick $u MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom
700    1_
$a Langenberg, Claudia $u MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom
700    1_
$a Winpenny, Eleanor $u MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom
700    1_
$a Dunger, David $u Department of Paediatrics, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom
700    1_
$a Jones, Peter B $u Department of Psychiatry, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom $u Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, United Kingdom
700    1_
$a Khandaker, Golam M $u Department of Psychiatry, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom $u Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, United Kingdom $u Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom $u MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
773    0_
$w MED00180928 $t JAMA psychiatry $x 2168-6238 $g Roč. 78, č. 4 (2021), s. 416-425
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33439216 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506131040 $b ABA008
999    __
$a ok $b bmc $g 1789903 $s 1163696
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 78 $c 4 $d 416-425 $e 20210401 $i 2168-6238 $m JAMA psychiatry $n JAMA Psychiatry $x MED00180928
GRA    __
$a MC_UU_12015/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a MR/L010305/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a 201486/Z/16/Z $p Wellcome Trust $2 United Kingdom
GRA    __
$a MC_PC_15018 $p Medical Research Council $2 United Kingdom
GRA    __
$a G9815508 $p Medical Research Council $2 United Kingdom
GRA    __
$a 102215/2/13/2 $p Wellcome Trust $2 United Kingdom
GRA    __
$a MR/T010576/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a MC_PC_17213 $p Medical Research Council $2 United Kingdom
GRA    __
$a 217065/Z/19/Z $p Wellcome Trust $2 United Kingdom
GRA    __
$a MR/S037675/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a MC_UU_00006/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a 08426812/Z/07/Z $p Wellcome Trust $2 United Kingdom
GRA    __
$a MC_PC_19009 $p Medical Research Council $2 United Kingdom
GRA    __
$a MR/M006727/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a DRF-2018-11-ST2-018 $p Department of Health $2 United Kingdom
LZP    __
$a Pubmed-20220425

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...